Dopaminergic neuronal death via necroptosis in Parkinson's disease: A review of the literature
European Journal of Neuroscience · 2024-03 · 59 (6) · 1079-1098
DOI: 10.1111/ejn.16136 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Neuroscience, online erschienen am 05.09.2023. Verfasst von Maria Regoni und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy. Hauptthemen laut MEDLINE: Dopaminergic Neurons, Parkinson Disease. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Union - Next Generation EU, Italian Ministry of Health, Telethon Foundation.
Abstract (Originalsprache)
Parkinson's disease (PD) is a neurodegenerative disorder characterized by progressive dysfunction and loss of dopaminergic neurons of the substantia nigra pars compacta (SNc). Several pathways of programmed cell death are likely to play a role in dopaminergic neuron death, such as apoptosis, necrosis, pyroptosis and ferroptosis, as well as cell death associated with proteasomal and mitochondrial dysfunction. A better understanding of the molecular mechanisms underlying dopaminergic neuron death could inform the design of drugs that promote neuron survival. Necroptosis is a recently characterized regulated cell death mechanism that exhibits morphological features common to both apoptosis and necrosis. It requires activation of an intracellular pathway involving receptor‐interacting protein 1 kinase (RIP1 kinase, RIPK1), receptor‐interacting protein 3 kinase (RIP3 kinase, RIPK3) and mixed lineage kinase domain‐like pseudokinase (MLKL). The potential involvement of this programmed cell death pathway in the pathogenesis of PD has been studied by analysing biomarkers for necroptosis, such as the levels and oligomerization of phosphorylated RIPK3 (pRIPK3) and phosphorylated MLKL (pMLKL), in several PD preclinical models and in PD human tissue. Although there is evidence that other types of cell death also have a role in DA neuron death, most studies support the hypothesis that this cell death mechanism is activated in PD tissues. Drugs that prevent or reduce necroptosis may provide neuroprotection for PD. In this review, we summarize the findings from these studies. We also discuss how manipulating necroptosis might open a novel therapeutic approach to reduce neuronal degeneration in PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
- Vita-Salute San Raffaele University, Milan, Italy.
ORCID-Profile: Jenny Sassone
Förderung
- European Union - Next Generation EU
- Italian Ministry of Health
- Telethon Foundation
- Italian Ministry of University and Research
- European Union-Next Generation EU
- Ministero della Salute
- Fondazione Telethon
- Ministero dell’Istruzione, dell’Università e della Ricerca
Zitieren
APA
Regoni, M., Valtorta, F., & Sassone, J. (2024). Dopaminergic neuronal death via necroptosis in Parkinson's disease: A review of the literature. European Journal of Neuroscience, 59(6), 1079-1098. https://doi.org/10.1111/ejn.16136
Vancouver
Regoni M, Valtorta F, Sassone J. Dopaminergic neuronal death via necroptosis in Parkinson's disease: A review of the literature. European Journal of Neuroscience. 2024;59(6):1079-1098. doi:10.1111/ejn.16136
BibTeX
@article{Regoni2024,
author = {Regoni, Maria and Valtorta, Flavia and Sassone, Jenny},
title = {Dopaminergic neuronal death via necroptosis in Parkinson's disease: A review of the literature},
journal = {European Journal of Neuroscience},
year = {2024},
volume = {59},
number = {6},
pages = {1079--1098},
doi = {10.1111/ejn.16136}
}
EUVIMED